ESPERITE (ESP) announces publication of its Annual Report 2017 before 24 November 2018

Amsterdam, The Netherlands - 19 November 2018

Esperite announces that the preparation of its Annual Report 2017 is now under final review by its auditors and should be published before 24 November 2018.

About ESPERITE
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - ir@esperite.com or visit the websites at www.esperite.com,  www.genoma.com and www.cryo-save.com.

***

This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

Attachment

• Announcement publication AR 2017.pdf